{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T12:03:14Z","timestamp":1782907394736,"version":"3.54.5"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["PTDC\/PSI-GER\/28076\/2017"],"award-info":[{"award-number":["PTDC\/PSI-GER\/28076\/2017"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.pupt.2021.102008","type":"journal-article","created":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T23:36:58Z","timestamp":1615678618000},"page":"102008","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Sequential doxycycline and colchicine combination therapy in Covid-19: The salutary effects"],"prefix":"10.1016","volume":"67","author":[{"given":"Hayder M.","family":"Al-kuraishy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali I.","family":"Al-Gareeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naeem","family":"Qusty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nat\u00e1lia","family":"Cruz-Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaber","family":"El-Saber Batiha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pupt.2021.102008_bib1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4103\/bbrj.bbrj_103_20","article-title":"Macrolides and COVID-19: an optimum premise","volume":"4","author":"Al-Kuraishy","year":"2020","journal-title":"Biomed. Biotechnol. Res. J. (BBRJ)"},{"key":"10.1016\/j.pupt.2021.102008_bib2","first-page":"71","article-title":"Hyperbilirubinemia in Gilbert syndrome attenuates Covid-19 induced-metabolic disturbances: a case-report study","volume":"8","author":"Al-Kuraishy","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.pupt.2021.102008_bib3","doi-asserted-by":"crossref","first-page":"644295","DOI":"10.3389\/fmed.2021.644295","article-title":"COVID-19 and risk of acute ischemic stroke and acute lung injury in patients with type II diabetes mellitus: the anti-inflammatory role of metformin","volume":"8","author":"Al-kuraishy","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.pupt.2021.102008_bib4","first-page":"15","article-title":"From SARS-CoV to nCoV-2019: ruction and argument","author":"Al-Kuraishy","year":"2020","journal-title":"Arch. Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.pupt.2021.102008_bib5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41591-020-0796-5","article-title":"Emergence of a novel human coronavirus threatening human health","volume":"26","author":"Poon","year":"2020","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.pupt.2021.102008_bib6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4103\/bbrj.bbrj_105_20","article-title":"Renin\u2013Angiotensin system and fibrinolytic pathway in COVID-19: one-way skepticism","volume":"4","author":"Al-Kuraishy","year":"2020","journal-title":"Biomed. Biotechnol. Res. J. (BBRJ)"},{"key":"10.1016\/j.pupt.2021.102008_bib7","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.3389\/fmicb.2020.593857","article-title":"Comparative transcriptome analysis reveals the intensive early stage responses of host cells to SARS-CoV-2 infection","volume":"11","author":"Sun","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.pupt.2021.102008_bib8","doi-asserted-by":"crossref","first-page":"114431","DOI":"10.1016\/j.bcp.2021.114431","article-title":"PDE4 inhibition as a therapeutic strategy for improvement of pulmonary dysfunctions in Covid-19 and cigarette smoking","author":"Lugnier","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.pupt.2021.102008_bib9","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4103\/2305-0500.282984","article-title":"COVID-19 pneumonia in an Iraqi pregnant woman with preterm delivery","volume":"9","author":"Al-kuraishy","year":"2020","journal-title":"Asian Pacific J. Reprod."},{"issue":"5","key":"10.1016\/j.pupt.2021.102008_bib10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4103\/bbrj.bbrj_109_20","article-title":"Is ivermectin\u2013Azithromycin combination the next step for COVID-19?","volume":"4","author":"Al-Kuraishy","year":"2020","journal-title":"Biomed. Biotechnol. Res. J. (BBRJ)"},{"key":"10.1016\/j.pupt.2021.102008_bib11","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ejmech.2019.03.025","article-title":"Anti-tubulin agents of natural origin: targeting taxol, vinca, and colchicine binding domains","volume":"171","author":"Naaz","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.pupt.2021.102008_bib12","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.atherosclerosis.2017.12.027","article-title":"The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation","volume":"269","author":"Mart\u00ednez","year":"2018","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.pupt.2021.102008_bib13","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/bjd.15896","article-title":"Colchicine: an ancient drug with novel applications","volume":"178","author":"Dasgeb","year":"2018","journal-title":"Br. J. Dermatol."},{"issue":"6","key":"10.1016\/j.pupt.2021.102008_bib14","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.13136","article-title":"Effect of colchicine vs standard care on cardiac and inflammatory biomarkers and clinical outcomes in patients hospitalized with coronavirus disease 2019: the GRECCO-19 randomized clinical trial","volume":"3","author":"Deftereos","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"2","key":"10.1016\/j.pupt.2021.102008_bib15","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaad.2005.10.004","article-title":"Tetracyclines: nonantibiotic properties and their clinical implications","volume":"54","author":"Sapadin","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"issue":"5","key":"10.1016\/j.pupt.2021.102008_bib16","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/phar.2395","article-title":"Therapeutic potential for tetracyclines in the treatment of COVID\u201019. Pharmacotherapy","volume":"40","author":"Sodhi","year":"2020","journal-title":"J. Human Pharmacol. Drug Ther."},{"key":"10.1016\/j.pupt.2021.102008_bib17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.intimp.2019.04.015","article-title":"Doxycycline alleviates paraquat-induced acute lung injury by inhibiting neutrophil-derived matrix metalloproteinase 9","volume":"72","author":"Zhang","year":"2019","journal-title":"Int. Immunopharm."},{"issue":"1","key":"10.1016\/j.pupt.2021.102008_bib18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2174\/1574891X10666150410153839","article-title":"Dengue patients treated with doxycycline showed lower mortality associated to a reduction in IL-6 and TNF levels","volume":"10","author":"M Fredeking","year":"2015","journal-title":"Recent Pat. Anti-Infect. Drug Discov."},{"issue":"21","key":"10.1016\/j.pupt.2021.102008_bib19","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.3390\/molecules25215064","article-title":"In vitro antiviral activity of doxycycline against SARS-CoV-2","volume":"25","author":"Gendrot","year":"2020","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.pupt.2021.102008_bib20","doi-asserted-by":"crossref","first-page":"107666","DOI":"10.1016\/j.jdiacomp.2020.107666","article-title":"Clinical analysis of risk factors for severe COVID-19 patients with type 2 diabetes","volume":"34","author":"Zhang","year":"2020","journal-title":"J. Diabetes Complicat."},{"key":"10.1016\/j.pupt.2021.102008_bib30","first-page":"10","article-title":"A potential therapeutic tool against COVID-19. Experience of 5 patients","author":"Montealegre-G\u00f3mez","year":"2020","journal-title":"Reumatol. Cl\u00ednica"},{"issue":"12","key":"10.1016\/j.pupt.2021.102008_bib21","doi-asserted-by":"crossref","first-page":"6808","DOI":"10.1007\/s00330-020-07033-y","article-title":"Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis","volume":"30","author":"Francone","year":"2020","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.pupt.2021.102008_bib22","article-title":"Lung fibrosis: an undervalued finding in COVID-19 pathological series","volume":"0","author":"Grillo","year":"2020","journal-title":"Lancet Infect. Dis."},{"issue":"8","key":"10.1016\/j.pupt.2021.102008_bib23","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41565-020-0752-z","article-title":"Dexamethasone nanomedicines for COVID-19","volume":"15","author":"Lammers","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.pupt.2021.102008_bib24","doi-asserted-by":"crossref","DOI":"10.1177\/1753466620951053","article-title":"Doxycycline treatment of high-risk COVID-19-positive patients with comorbid pulmonary disease","volume":"14","author":"Yates","year":"2020","journal-title":"Ther. Adv. Respir. Dis."},{"issue":"4","key":"10.1016\/j.pupt.2021.102008_bib25","doi-asserted-by":"crossref","first-page":"e13437","DOI":"10.1111\/dth.13437","article-title":"Doxycycline, a widely used antibiotic in dermatology with a possible anti\u2010inflammatory action against IL\u20106 in COVID\u201019 outbreak","volume":"33","author":"Conforti","year":"2020","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.pupt.2021.102008_bib26","article-title":"Entry of SARS-CoV2 through the basal surface of alveolar endothelial cells\u2013A proposed mechanism mediated by CD147 in COVID-19","volume":"2020050359","author":"Acosta","year":"2020","journal-title":"Preprints"},{"issue":"21","key":"10.1016\/j.pupt.2021.102008_bib27","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.3390\/molecules25215064","article-title":"In vitro antiviral activity of doxycycline against SARS-CoV-2","volume":"25","author":"Gendrot","year":"2020","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.pupt.2021.102008_bib28","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1097\/ICO.0b013e318053387f","article-title":"Interaction of doxycycline and warfarin: an enhanced anticoagulant effect","volume":"26","author":"Hasan","year":"2007","journal-title":"Cornea"},{"issue":"7","key":"10.1016\/j.pupt.2021.102008_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11886-020-01328-8","article-title":"The role of anticoagulation in COVID-19-induced hypercoagulability","volume":"22","author":"Rico-Mesa","year":"2020","journal-title":"Curr. Cardiol. Rep."},{"issue":"8","key":"10.1016\/j.pupt.2021.102008_bib31","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1007\/s10067-020-05232-y","article-title":"The rationale for the use of colchicine in COVID-19: comments on the letter by Cumhur Cure M et al","volume":"39","author":"Piantoni","year":"2020","journal-title":"Clin. Rheumatol."},{"issue":"4","key":"10.1016\/j.pupt.2021.102008_bib32","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/ehjcvp\/pvaa033","article-title":"Colchicine as a potent anti-inflammatory treatment in COVID-19: can we teach an old dog new tricks?","volume":"6","author":"Deftereos","year":"2020","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"issue":"10","key":"10.1016\/j.pupt.2021.102008_bib33","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1136\/annrheumdis-2020-217712","article-title":"Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome","volume":"79","author":"Scarsi","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.pupt.2021.102008_bib34","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJMc2009567","article-title":"Covid-19 in immune-mediated inflammatory diseases\u2014case series from New York","volume":"383","author":"Haberman","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.pupt.2021.102008_bib35","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1136\/annrheumdis-2020-218122","article-title":"Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study","volume":"79","author":"Della-Torre","year":"2020","journal-title":"Ann. Rheum. Dis."},{"issue":"108490","key":"10.1016\/j.pupt.2021.102008_bib36","first-page":"1","article-title":"Treating COVID-19 with colchicine in community healthcare setting","volume":"217","author":"Della-Torre","year":"2020","journal-title":"Clin. Immunol."},{"issue":"6","key":"10.1016\/j.pupt.2021.102008_bib37","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.13136","article-title":"Effect of colchicine vs standard care on cardiac and inflammatory biomarkers and clinical outcomes in patients hospitalized with coronavirus disease 2019: the GRECCO-19 randomized clinical trial","volume":"3","author":"Deftereos","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"12","key":"10.1016\/j.pupt.2021.102008_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0242318","article-title":"Colchicine reduces lung injury in experimental acute respiratory distress syndrome","volume":"15","author":"Dupuis","year":"2020","journal-title":"PloS One"},{"issue":"e39","key":"10.1016\/j.pupt.2021.102008_bib39","article-title":"COVID-19 infection in a patient with FMF: does colchicine have a protective effect?","volume":"80","author":"Kobak","year":"2020","journal-title":"Ann. Rheum. Dis."},{"issue":"9\u201310","key":"10.1016\/j.pupt.2021.102008_bib40","first-page":"525","article-title":"Protective effect of colchicine on LPS-induced lung injury in rats via inhibition of P-38, ERK1\/2, and JNK activation","volume":"105","author":"Yue","year":"2020","journal-title":"Pharmacology"},{"key":"10.1016\/j.pupt.2021.102008_bib41","unstructured":"Vrachatis DA, Giannopoulos GV, Giotaki SG, Raisakis K, Kossyvakis C, Iliodromitis KE, Reimers B, Tousoulis D, Cleman M, Stefanadis C, Lansky A. Impact of colchicine on mortality in patients with COVID-19. A meta-analysis. Hellenic J. Cardiol. HJC: HJC= Hellenike kardiologike epitheorese.:S1109-S9666."},{"issue":"4","key":"10.1016\/j.pupt.2021.102008_bib42","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/cmdc.201800641","article-title":"Synthesis, biological evaluation, and molecular docking of combretastatin and colchicine derivatives and their hCE1\u2010activated prodrugs as antiviral agents","volume":"14","author":"Richter","year":"2019","journal-title":"ChemMedChem"},{"key":"10.1016\/j.pupt.2021.102008_bib43","first-page":"1","article-title":"Coronaviruses: an updated overview of their replication and pathogenesis","author":"Wang","year":"2020","journal-title":"Coronaviruses"},{"key":"10.1016\/j.pupt.2021.102008_bib44","first-page":"1","article-title":"Efficacy of colchicine in non-hospitalized patients with COVID-19","author":"Tardif","year":"2021","journal-title":"Medrxiv"},{"issue":"7","key":"10.1016\/j.pupt.2021.102008_bib45","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1111\/jdv.16525","article-title":"Expert recommendations for the management of autoimmune bullous diseases during the COVID\u201019 pandemic","volume":"34","author":"Kasperkiewicz","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.pupt.2021.102008_bib46","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3329\/jbcps.v38i0.47512","article-title":"A case series of 100 COVID-19 positive patients treated with combination of ivermectin and doxycycline","author":"Alam","year":"2020","journal-title":"J. Bangladesh Coll. Phys. Surg."},{"issue":"5","key":"10.1016\/j.pupt.2021.102008_bib47","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1021\/acsptsci.0c00140","article-title":"Ivermectin, famotidine, and doxycycline: a suggested combinatorial therapeutic for the treatment of COVID-19","volume":"3","author":"Sen Gupta","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"36","key":"10.1016\/j.pupt.2021.102008_bib48","first-page":"99","article-title":"The efficacy of colchicine in the management of coronavirus disease 2019: a protocol for systematic review and meta-analysis","author":"Elshafei","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.pupt.2021.102008_bib49","doi-asserted-by":"crossref","first-page":"110054","DOI":"10.1016\/j.mehy.2020.110054","article-title":"Doxycycline or minocycline may be a viable treatment option against SARS-CoV-2","volume":"144","author":"Francini","year":"2020","journal-title":"Med. Hypotheses"},{"issue":"4","key":"10.1016\/j.pupt.2021.102008_bib50","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4103\/jgid.jgid_296_20","article-title":"Colchicine, aspirin, and montelukast\u2013A case of successful combined pharmacotherapy for adult multisystem inflammatory syndrome in COVID-19","volume":"12","author":"Downing","year":"2020","journal-title":"J. Global Infect. Dis."},{"key":"10.1016\/j.pupt.2021.102008_bib51","doi-asserted-by":"crossref","first-page":"109768","DOI":"10.1016\/j.mehy.2020.109768","article-title":"Dapsone and doxycycline could be potential treatment modalities for COVID-19","volume":"140","author":"Farouk","year":"2020","journal-title":"Med. Hypotheses"},{"issue":"1","key":"10.1016\/j.pupt.2021.102008_bib52","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/ced.12692","article-title":"Doxycycline\u2010induced hypoglycaemia","volume":"41","author":"Tan","year":"2016","journal-title":"Clin. Exp. Dermatol."}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553921000201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553921000201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:30:29Z","timestamp":1761082229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553921000201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":52,"alternative-id":["S1094553921000201"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2021.102008","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sequential doxycycline and colchicine combination therapy in Covid-19: The salutary effects","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2021.102008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102008"}}